A recent study investigated the effects of intensive systolic blood pressure treatment on cardiovascular outcomes among participants with prediabetes and normoglycemia.
Previous studies have shown that cardiovascular disease risk is highest among patients at or above 140/90 mm Hg. However, a new review may contradict this evidence. To see results of the study, including...
Researchers investigated the value of cumulative systolic and diastolic BP measurements in the prediction of future cardiovascular events and all-cause mortality.
Errors in at-home or in-office BP measurement can affect the reading’s results, which in turn can impact BP management. At Consultant360’s Cardiometabolic Risk Summit 2019, F. Wilford Germino, MD, provided...
In response to the recent lowering of blood pressure targets in high-risk patients, a new study compared the effects of standard and more-intense BP-lowering regimens.
Researchers aimed to determine whether the presence of an attendant impacted the white coat effect and whether in-office or ambulatory blood pressure monitoring is better for making a diagnosis of...
